Lifecore Biomedical, Inc. also files under LNDC; those filings are included. Filings under LFCR by Lifecore Biomedical Inc (CIK 0000028626) from Nov 25, 2022 to Jan 9, 2023 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Antunes Humberto Calheiros | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Houde Lovas Katrina | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Kiper Christopher S | Director, 10% Owner | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Schechter Joshua | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Obus Nelson | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Aryeh Jason | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Johnson Paul Harold | Director | Grant(A) | 26K | — | — |
| Jun 4, 2026 | Korenberg Matthew E | Director | Grant(A) | 26K | — | — |
| May 20, 2026 | Josephs Paul | Chief Executive Officer, Director | Tax withholding(F) | 40K | $4.57 | $185K |
| Apr 14, 2026 | Salus Thomas D. | Chief Legal & Administration | Tax withholding(F) | 25K | $5.20 | $128K |
| Mar 2, 2026 | Salus Thomas D. | Chief Legal & Administration | Grant(A) | 30K | — | — |
| Sep 3, 2025 | Lake Ryan David | Chief Financial Officer | Tax withholding(F) | 23K | $7.71 | $177K |
| Jul 15, 2025 | Aryeh Jason | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Obus Nelson | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Johnson Paul Harold | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Antunes Humberto Calheiros | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Houde Lovas Katrina | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Korenberg Matthew E | Director | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Legion Partners Holdings, LLC | Director, 10% Owner | Grant(A) | 20K | — | — |
| Jul 15, 2025 | Schechter Joshua | Director | Grant(A) | 20K | — | — |
| Jul 8, 2025 | Salus Thomas D. | Chief Legal & Administration | Option exercise(M) | 37K | — | — |
| Jul 8, 2025 | Lake Ryan David | Chief Financial Officer | Option exercise(M) | 75K | — | — |
| Jul 8, 2025 | Josephs Paul | Chief Executive Officer, Director | Option exercise(M) | 150K | — | — |
| Jul 8, 2025 | Josephs Paul | Chief Executive Officer, Director | Tax withholding(F) | 55K | $8.19 | $449K |
| Jul 8, 2025 | Salus Thomas D. | Chief Legal & Administration | Option exercise(M) | 37K | — | — |
| Jul 8, 2025 | Salus Thomas D. | Chief Legal & Administration | Tax withholding(F) | 11K | $8.19 | $90K |
| Jul 8, 2025 | Lake Ryan David | Chief Financial Officer | Option exercise(M) | 75K | — | — |
| Jul 8, 2025 | Lake Ryan David | Chief Financial Officer | Tax withholding(F) | 33K | $8.19 | $269K |
| Jul 8, 2025 | Josephs Paul | Chief Executive Officer, Director | Option exercise(M) | 150K | — | — |
| May 28, 2025 | English Aron R. | 10% Owner | Sell(S) | 150K | $7.12 | $1.1M |
| May 27, 2025 | English Aron R. | 10% Owner | Sell(S) | 1.1M | $6.50 | $7.4M |
| May 23, 2025 | English Aron R. | 10% Owner | Sell(S) | 96K | $6.75 | $649K |
| May 20, 2025 | Josephs Paul | Chief Executive Officer, Director | Tax withholding(F) | 22K | $6.63 | $143K |
| May 13, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell(S) | 12K | $7.00 | $86K |
| May 12, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell(S) | 46K | $7.03 | $321K |
| May 9, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell(S) | 700 | $7.00 | $5K |
| May 8, 2025 | 22NW Fund GP, LLC | 10% Owner | Sell(S) | 5K | $7.00 | $36K |
| May 7, 2025 | 22NW GP, Inc. | 10% Owner | Sell(S) | 16K | $7.01 | $111K |
| May 6, 2025 | 22NW GP, Inc. | 10% Owner | Sell(S) | 701 | $7.05 | $5K |
| May 5, 2025 | 22NW GP, Inc. | 10% Owner | Sell(S) | 25K | $7.08 | $174K |
| Apr 14, 2025 | Salus Thomas D. | Chief Legal & Administration | Grant(A) | 45K | — | — |
| Apr 14, 2025 | Salus Thomas D. | Chief Legal & Administration | Grant(A) | 210K | — | $0 |
| Apr 14, 2025 | Salus Thomas D. | Chief Legal & Administration | Grant(A) | 370K | — | $0 |
| Apr 14, 2025 | Salus Thomas D. | Chief Legal & Administration | Grant(A) | 170K | — | — |
| Jan 8, 2025 | Josephs Paul | Chief Executive Officer, Director | Buy(P) | 17K | $5.74 | $98K |
| Dec 6, 2024 | Josephs Paul | Chief Executive Officer, Director | Grant(A) | 38K | — | $0 |
| Dec 6, 2024 | Lake Ryan David | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Dec 6, 2024 | Lake Ryan David | Chief Financial Officer | Tax withholding(F) | 6K | $7.15 | $40K |
| Dec 6, 2024 | Josephs Paul | Chief Executive Officer, Director | Tax withholding(F) | 12K | $7.15 | $84K |
| Oct 7, 2024 | Lake Ryan David | Chief Financial Officer | Tax withholding(F) | 34K | $5.09 | $174K |
| Oct 7, 2024 | Lake Ryan David | Chief Financial Officer | Option exercise(M) | 75K | — | — |
| Oct 3, 2024 | Legion Partners Asset Management, LLC | Director, 10% Owner | Buy(P) | 1.3M | $4.10 | $5.4M |
| Oct 3, 2024 | Wynnefield Capital, Inc. Profit Sharing Plan | 10% Owner | Buy(P) | 123K | $4.10 | $504K |
| Oct 3, 2024 | Legion Partners Asset Management, LLC | Director, 10% Owner | Buy(P) | 152K | $4.10 | $624K |
| Oct 3, 2024 | Wynnefield Capital, Inc. Profit Sharing Plan | 10% Owner | Buy(P) | 170K | $4.10 | $696K |
| Sep 3, 2024 | Lake Ryan David | Chief Financial Officer | Grant(A) | 750K | — | $0 |
| Sep 3, 2024 | Lake Ryan David | Chief Financial Officer | Grant(A) | 263K | — | — |
| Aug 19, 2024 | Antunes Humberto Calheiros | Director | Grant(A) | 25K | — | — |
| Aug 19, 2024 | Korenberg Matthew E | Director | Grant(A) | 25K | — | — |
| Aug 19, 2024 | Johnson Paul Harold | Director | Grant(A) | 25K | — | — |
| Aug 19, 2024 | Aryeh Jason | Director | Grant(A) | 25K | — | — |
| Jul 8, 2024 | Calloway Nathaniel | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Diradoorian Raymond H | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Edwards Jeffrey L | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Houde Lovas Katrina | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Obus Nelson | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Schechter Joshua | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Kiper Christopher S | Director | Grant(A) | 30K | — | — |
| Jul 8, 2024 | Barbarosh Craig A. | Director | Grant(A) | 30K | — | — |
| May 20, 2024 | Josephs Paul | Chief Executive Officer, Director | Grant(A) | 1.5M | — | $0 |
| May 20, 2024 | Josephs Paul | Chief Executive Officer, Director | Tax withholding(F) | 9K | — | — |
| May 20, 2024 | Josephs Paul | Chief Executive Officer, Director | Grant(A) | 525K | — | — |
| Feb 1, 2024 | Obus Nelson | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Schechter Joshua | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Schechter Joshua | Director | Option exercise(M) | 10K | — | — |
| Feb 1, 2024 | Calloway Nathaniel | Director | Option exercise(M) | 4K | — | $0 |
| Feb 1, 2024 | Calloway Nathaniel | Director | Option exercise(M) | 4K | — | — |
| Feb 1, 2024 | Edwards Jeffrey L | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Edwards Jeffrey L | Director | Option exercise(M) | 10K | — | — |
| Feb 1, 2024 | Diradoorian Raymond H | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Diradoorian Raymond H | Director | Option exercise(M) | 10K | — | — |
| Feb 1, 2024 | Houde Lovas Katrina | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Houde Lovas Katrina | Director | Option exercise(M) | 10K | — | — |
| Feb 1, 2024 | Barbarosh Craig A. | Director | Option exercise(M) | 10K | — | $0 |
| Feb 1, 2024 | Barbarosh Craig A. | Director | Option exercise(M) | 10K | — | — |
| Feb 1, 2024 | Obus Nelson | Director | Option exercise(M) | 10K | — | — |
| Jan 18, 2024 | Morberg John D | Chief Financial Officer | Option exercise(M) | 18K | — | $0 |
| Jan 18, 2024 | Morberg John D | Chief Financial Officer | Tax withholding(F) | 6K | — | — |
| Jan 18, 2024 | Morberg John D | Chief Financial Officer | Option exercise(M) | 18K | — | — |
| Jan 9, 2024 | Calloway Nathaniel | Director | Option exercise(M) | 6K | — | $0 |
| Jan 9, 2024 | Calloway Nathaniel | Director | Option exercise(M) | 6K | — | — |
| Jun 1, 2023 | Morberg John D | Chief Financial Officer | Grant(A) | 50K | — | — |
| Jun 1, 2023 | Calloway Nathaniel | Director | Grant(A) | 18K | — | — |
| Jun 1, 2023 | Morberg John D | Chief Financial Officer | Grant(A) | 45K | — | — |
| Jun 1, 2023 | Hall James G | Chief Executive Officer, Director | Grant(A) | 75K | — | — |
| Jun 1, 2023 | Hall James G | Chief Executive Officer, Director | Grant(A) | 150K | — | — |
| Jun 1, 2023 | Legion Partners, L.P. II | Director | Grant(A) | 18K | — | — |
| Jun 1, 2023 | Schechter Joshua | Director | Grant(A) | 18K | — | — |
| Jun 1, 2023 | Obus Nelson | Director | Grant(A) | 18K | — | — |
| Jun 1, 2023 | Houde Lovas Katrina | Director | Grant(A) | 18K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Lifecore Biomedical, Inc., SEC CIK 0001005286. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under LFCR and shows every filing by that issuer (also filed as LNDC). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for LFCR